Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian indices continue to slide
Mon, 3 Jun 01:30 pm

Led by persistent selling activity, Indian equity markets continued to trade weak during the post noon trading session. Barring IT and metal sectors, all the sectoral indices are trading in the negative territory. Stocks from the oil and gas and capital goods sector are witnessing maximum selling pressure.

BSE-Sensex is down by 161 points and NSE-Nifty is trading down by 62 points. While BSE Mid Cap is trading down by 0.01%, BSE Small Cap index is trading down by 0.03%. The rupee is trading at 56.63 to the US dollar.

Majority of the mining stocks are trading in the red with Gujarat NRE Coke and Sesa Goa being the biggest losers. However, Ashapura Minechem and Coal India Ltd (CIL) are trading strongly. As per a leading financial daily, the Coal Minister has said that the government is prepared to split CIL into small companies in order to promote healthy competition and boost production. The government wants to encourage public-private partnership (PPP) in coal and encourage development of state-owned mines by private firms to increase efficiency and reduce the scope of fraudulent practices. The government had invited consultants to study the structure of Coal India and recommend changes. The decision on spinning off CIL's subsidiaries will be taken on the basis of the report which is likely to be released by December 2013. CIL stock is currently up 0.8%.

Domestic pharma stocks are trading mixed. While Torrent Pharma and Aurobindo Ltd are leading among the gainers, Panacea Biotech and Orchid Chemicals were out of favour. Dr Reddy's Ltd has called off the deal signed with Japan's Fujifilm Corporation. Both the companies have decided to terminate the memorandum of understanding (MOU), signed in July 2011. As per the MOU, both the companies entered into a joint venture (JV) for generic drug formulations in Japan. However, as Fujifilm has realigned its long term growth strategy for it pharmaceutical segment, both the companies agreed to terminate the partnership. Reportedly, both the companies will continue to explore future opportunities in other pharmaceutical verticals such as API (active pharmaceutical ingredients), contract manufacturing etc. One should note that Dr Reddy's was not generating any revenues from this JV. Dr Reddy's was trading up by 1.2%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Indian indices continue to slide". Click here!

  

Related Views on News

Sorry! There are no related views on news for this company/sector.

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living (Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Feb 26, 2021 (Close)

S&P BSE HEALTHCARE 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS